Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SNIP1 encodes a protein that contains a coiled-coil motif and C-terminal forkhead-associated (FHA) domain. Additionally we are shipping SNIP1 Proteins (8) and SNIP1 Kits (4) and many more products for this protein.
Showing 10 out of 56 products:
Human Polyclonal SNIP1 Primary Antibody for EIA, WB - ABIN954871
Bracken, Wall, Barré, Panov, Ajuh, Perkins: Regulation of cyclin D1 RNA stability by SNIP1. in Cancer research 2008
Show all 5 references for ABIN954871
Cow (Bovine) Polyclonal SNIP1 Primary Antibody for WB - ABIN2778020
Roche, Wiechens, Owen-Hughes, Perkins: The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. in Oncogene 2004
Human Polyclonal SNIP1 Primary Antibody for IP, WB - ABIN151953
Yu, Bi, Zheng, Ji, Chevalier, Agarwal, Ramachandran, Li, Lagrange, Walker, Chen: The FHA domain proteins DAWDLE in Arabidopsis and SNIP1 in humans act in small RNA biogenesis. in Proceedings of the National Academy of Sciences of the United States of America 2008
SUMOylation of SNIP1 leads to the loss of SNIP1-mediated inhibition on expression of the TGF-beta (show TGFB1 Antibodies) target genes PAI-1 (show SERPINE1 Antibodies) and MMP2 (show MMP2 Antibodies) and eventually enhances TGF-beta (show TGFB1 Antibodies)-regulated cell migration and invasion.
Involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 (show HDAC1 Antibodies) interaction.
SNIP1 in cells strongly activated the heat shock element signaling pathway, and SNIP1 might selectively regulate the transcription of some heat shock proteins through associating with heat shock elements
Study identified sequence variants in the known disease-causing genes SLC6A3 (show SLC6A3 Antibodies) and FLVCR1 (show FLVCR1 Antibodies), and present evidence to strongly support the pathogenicity of variants identified in TUBGCP6 (show TUBGCP6 Antibodies), BRAT1 (show C7orf27 Antibodies), SNIP1, CRADD (show CRADD Antibodies), and HARS (show HARS Antibodies).
overexpression of HIF-1alpha (show HIF1A Antibodies), TWIST2 (show TWIST2 Antibodies) or SNIP1 correlated with poor disease-free survival in patients with tongue squamous cell carcinoma
define both a new function for SNIP1 and identify a previously unrecognized regulator of the cell cycle and cyclin D1 (show CCND1 Antibodies) expression
Smad (show SMAD1 Antibodies)-binding peptide (show HP Antibodies) aptamers can be developed to selectively inhibit TGF-beta (show TGFB1 Antibodies)-induced gene expression.
SNIP1 functions as a regulator of c-Myc (show MYC Antibodies) activity, binding the N c-Myc (show MYC Antibodies) N terminus through its C terminus, and that SNIP1 enhances the transcriptional activity of c-Myc (show MYC Antibodies) by stabilizing it against proteosomal degradation and bridging the c-Myc (show MYC Antibodies)/p300 (show EP300 Antibodies) complex.
SNIP1, the human homolog of DDL, is involved in miRNA biogenesis and interacts with Drosha (show DROSHA Antibodies)
Study shows a novel mechanism regulating Cyclin D1 (show CCND1 Antibodies) expression and offers new insight into the role of SNIP1 and associated proteins as regulators of proliferation and cancer.
This gene encodes a protein that contains a coiled-coil motif and C-terminal forkhead-associated (FHA) domain. The encoded protein functions as a transcriptional coactivator that increases c-Myc activity and inhibits transforming growth factor beta (TGF-beta) and nuclear factor kappa-B (NF-kB) signaling. The encoded protein also regulates the stability of cyclin D1 mRNA, and may play a role in cell proliferation and cancer progression. Mutations in this gene are a cause of psychomotor retardation, epilepsy, and craniofacial dysmorphism (PMRED).
Smad nuclear interacting protein 1
, Smad nuclear interacting protein 1 a
, smad nuclear interacting protein 1
, FHA domain-containing protein SNIP1
, smad nuclear-interacting protein 1
, Smad nuclear interacting protein 1 Snip1